• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form D filed by IMAC Holdings Inc.

    8/25/22 4:14:31 PM ET
    $IMAC
    Medical Specialities
    Health Care
    Get the next $IMAC alert in real time by email
    SEC FORM D

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM D

    Notice of Exempt Offering of Securities

    OMB APPROVAL
    OMB Number: 3235-0076
    Estimated average burden
    hours per response: 4.00

    1. Issuer's Identity

    CIK (Filer ID Number) Previous Names
       None
    Entity Type
    0001729944
    IMAC HOLDINGS LLC
    X Corporation
       Limited Partnership
       Limited Liability Company
       General Partnership
       Business Trust
       Other (Specify)

    Name of Issuer
    IMAC Holdings, Inc.
    Jurisdiction of Incorporation/Organization
    DELAWARE
    Year of Incorporation/Organization
       Over Five Years Ago
    X Within Last Five Years (Specify Year) 2018
       Yet to Be Formed

    2. Principal Place of Business and Contact Information

    Name of Issuer
    IMAC Holdings, Inc.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode Phone Number of Issuer
    Brentwood TENNESSEE 37027 (844) 266-4622

    3. Related Persons

    Last Name First Name Middle Name
    Ervin Jeffrey S.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Gardzina Sheri F.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Wallis Matthew C.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):

    President of IMAC Holdings, Inc.
    Last Name First Name Middle Name
    Lerner Ben
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Evans Maurice E.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Pruitt Michael D.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Sucoff Cary W.
    Street Address 1 Street Address 2
    1605 Westgate Circle
    City State/Province/Country ZIP/PostalCode
    Brentwood TENNESSEE 37027
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    4. Industry Group

       Agriculture
    Banking & Financial Services
       Commercial Banking
       Insurance
       Investing
       Investment Banking
       Pooled Investment Fund
    Is the issuer registered as
    an investment company under
    the Investment Company
    Act of 1940?
       Yes    No
       Other Banking & Financial Services
       Business Services
    Energy
       Coal Mining
       Electric Utilities
       Energy Conservation
       Environmental Services
       Oil & Gas
       Other Energy
    Health Care
       Biotechnology
       Health Insurance
       Hospitals & Physicians
       Pharmaceuticals
    X Other Health Care
       Manufacturing
    Real Estate
       Commercial
       Construction
       REITS & Finance
       Residential
       Other Real Estate
      
    Retailing
      
    Restaurants
    Technology
       Computers
       Telecommunications
       Other Technology
    Travel
       Airlines & Airports
       Lodging & Conventions
       Tourism & Travel Services
       Other Travel
      
    Other

    5. Issuer Size

    Revenue Range OR Aggregate Net Asset Value Range
       No Revenues    No Aggregate Net Asset Value
       $1 - $1,000,000    $1 - $5,000,000
       $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
    X $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
       $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
       Over $100,000,000    Over $100,000,000
       Decline to Disclose    Decline to Disclose
       Not Applicable    Not Applicable

    6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

       Rule 504(b)(1) (not (i), (ii) or (iii))
       Rule 504 (b)(1)(i)
       Rule 504 (b)(1)(ii)
       Rule 504 (b)(1)(iii)
    X Rule 506(b)
       Rule 506(c)
       Securities Act Section 4(a)(5)
       Investment Company Act Section 3(c)
       Section 3(c)(1)    Section 3(c)(9)  
       Section 3(c)(2)    Section 3(c)(10)
       Section 3(c)(3)    Section 3(c)(11)
       Section 3(c)(4)    Section 3(c)(12)
       Section 3(c)(5)    Section 3(c)(13)
       Section 3(c)(6)    Section 3(c)(14)
       Section 3(c)(7)

    7. Type of Filing

    X New Notice Date of First Sale 2022-08-16    First Sale Yet to Occur
       Amendment

    8. Duration of Offering

    Does the Issuer intend this offering to last more than one year?
       Yes X No

    9. Type(s) of Securities Offered (select all that apply)

       Equity    Pooled Investment Fund Interests
       Debt    Tenant-in-Common Securities
    X Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
       Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

    10. Business Combination Transaction

    Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
       Yes X No

    Clarification of Response (if Necessary):

    11. Minimum Investment

    Minimum investment accepted from any outside investor $0 USD

    12. Sales Compensation

    Recipient
    Recipient CRD Number    None
    Joseph Gunnar & Co., LLC 24795
    (Associated) Broker or Dealer X None
    (Associated) Broker or Dealer CRD Number X None
    None None
    Street Address 1 Street Address 2
    30 Broad Street 11th Floor
    City State/Province/Country ZIP/Postal Code
    New York NEW YORK 10004
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
    X Foreign/non-US
    CALIFORNIA
    ILLINOIS
    MINNESOTA
    NEVADA
    NEW YORK

    13. Offering and Sales Amounts

    Total Offering Amount $3,925,000 USD
    or    Indefinite
    Total Amount Sold $3,925,000 USD
    Total Remaining to be Sold $0 USD
    or    Indefinite

    Clarification of Response (if Necessary):

    14. Investors

      
    Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
    Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
    12

    15. Sales Commissions & Finder's Fees Expenses

    Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

    Sales Commissions $314,000 USD
       Estimate
    Finders' Fees $0 USD
       Estimate

    Clarification of Response (if Necessary):

    16. Use of Proceeds

    Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

    $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Signature and Submission

    Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

    Terms of Submission

    In submitting this notice, each issuer named above is:
    • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
    • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
    • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

    Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

    For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

    Issuer Signature Name of Signer Title Date
    IMAC Holdings, Inc. /s/ Jeffrey S. Ervin Jeffrey S. Ervin Chief Executive Officer 2022-08-25

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

    * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


    Get the next $IMAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IMAC

    DatePrice TargetRatingAnalyst
    8/19/2021$2.35 → $1.75Buy → Neutral
    National Alliance Securities
    More analyst ratings

    $IMAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:33 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:36 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:38 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    IMAC Holdings downgraded by National Alliance Securities with a new price target

    National Alliance Securities downgraded IMAC Holdings from Buy to Neutral and set a new price target of $1.75 from $2.35 previously

    8/19/21 11:40:11 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"

    BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health

    8/3/22 9:22:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

    BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe

    7/26/22 9:15:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    The Back Company demonstrates strong Q2 growth

    The Back Space sequential quarter traffic increased over 100% BRENTWOOD, Tenn., June 30, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), today announces significant traffic growth for The Back Company. The Back Space retail chiropractic centers, located in select Walmart stores, generated over 100% visit growth compared to the first quarter. "Our team's effort is evident as we continue to improve systems to support our doctors that delivered over 6,500 visits this calendar quarter," said Jeff Ervin, Chief Executive Officer of IMAC. "The Back Space growth for the second quarter will be a springboard to material revenue during the second half of the y

    6/30/22 9:20:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    SEC Filings

    View All

    SEC Form 10-Q filed by IMAC Holdings Inc.

    10-Q - IMAC Holdings, Inc. (0001729944) (Filer)

    11/14/22 5:25:58 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by IMAC Holdings Inc.

    EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)

    10/14/22 12:15:29 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)

    S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)

    10/7/22 5:01:30 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    1/23/23 10:00:08 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)

    SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)

    9/9/22 4:05:20 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    5/18/22 1:40:55 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Leadership Updates

    Live Leadership Updates

    View All

    IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer

    BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces the appointment of Sheri Gardzina, CPA as its Chief Financial Officer. To date, Ms. Gardzina has served as CFO in an interim capacity. “Sheri has been an excellent addition to our management team since joining the company and we are pleased to have her as our permanent Chief Financial Officer. She brings a wealth of financial and accounting experience to the company and I am excited to continue worki

    1/7/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Financials

    Live finance-specific insights

    View All

    IMAC Holdings Reports Third Quarter 2021 Financial Results and Provides Corporate Update

    BRENTWOOD, Tenn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the third quarter ended September 30, 2021. Financial Highlights from 3Q 2021 (all comparisons are with the quarter ended September 30, 2020, unless otherwise indicated): Total revenue was $3.49 million, compared with $3.48 millionTotal patient visits at IMAC Centers were up 10% to 43,451, compared to 39,345Net loss was $1.7 million, or a loss of $0.07 per share, compared with a net

    11/10/21 4:48:15 PM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Reports Second Quarter 2021 Financial Results

    IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets BRENTWOOD, Tenn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the second quarter ended June 30, 2021. Financial Highlights from 2Q 2021 (all comparisons are for the quarter ended June 30, 2020, unless otherwise indicated): Total revenue was $3.4 million, compared with $2.5 million, an increase o

    8/12/21 9:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Acquires Active Medical Center in Southwestern Chicago Suburb

    Naperville, Ill. purchase to be rebranded Mike Ditka IMAC Regeneration Center BRENTWOOD, Tenn., June 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the Company's expansion in the Chicago market with the asset purchase of Active Medical Center's Naperville, Illinois location, effective Monday, June 28. Active Medical Center is a medical clinic that addresses a wide variety of orthopedic treatments for various conditions through a combination of medical and physical rehabilitatio

    6/25/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care